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Previous studies have examinedDNAmethylation in different trinucleotide repeat diseases.We have combined this data and used a
pattern searching algorithm to identify motifs in the DNA surrounding aberrantly methylated CpGs found in the DNA of patients
with one of the three trinucleotide repeat (TNR) expansion diseases: fragile X syndrome (FRAXA), myotonic dystrophy type I
(DM1), or Friedreich’s ataxia (FRDA). We examined sequences surrounding both the variably methylated (VM) CpGs, which are
hypermethylated in patients compared with unaffected controls, and the nonvariably methylated CpGs which remain either always
methylated (AM) or nevermethylated (NM) in both patients and controls. Using the J48 algorithm ofWEKA analysis, we identified
that two patterns are all that is necessary to classify our three regions CCGG∗ which is found in VM and not in AM regions and
AATT∗ which distinguished between NM and VM + AM using proportional frequency. Furthermore, comparing our software
withMEME software, we have demonstrated that our software identifies more patterns thanMEME in these short DNA sequences.
Thus, we present evidence that the DNA sequence surrounding CpG can influence its susceptibility to be de novomethylated in a
disease state associated with a trinucleotide repeat.
1. Introduction
DNAmethylation involving the addition of amethyl group to
a CpG sequence is one of the mechanisms of gene regulation
commonly associated with transcriptional repression and is
necessary for mammalian development, X inactivation, and
genomic imprinting [1]. Gene silencing is a major biolog-
ical consequence of DNA methylation. The phenomenon
is widely reported in genes of both healthy cells, where it
assists in regulating gene expression during development,
for example, and diseased cells, where it is associated with
aberrant gene expression most notably in cancerous cells.
One group of diseases in which DNAmethylation is reported
to have an important role is TNR expansion diseases. Here,
we investigate the pattern of sequences in variablymethylated
(VM) and nonvariably methylated (AM always methylated
and NM never methylated) CpG sites of three TNR expan-
sion diseases: FRDA, FRAXA, and DM1 [2]. FRDA is an
inherited autosomal recessive neurodegenerative disorder
characterised by a homozygousGAArepeat expansionwithin
intron 1 sequence of the FXN gene [3]. The consequence of
the expanded GAA repeats is to reduce the expression of the
mitochondrial protein frataxin. Typically unaffected individ-
uals have 5–32 GAA repeats and affected individuals have
66–1700 repeats. FRAXA is a mental retardation disorder
associated with one of the seven folate-sensitive fragile sites
that have been identified within human chromosomes. All of
these sites have a large noncoding CGG repeat expansions.
FRAXA is the most prominent of the fragile site disorders
[4]. It is caused by repeat expansion with 5󸀠 UTR of the
FMR1 (fragile X mental retardation 1) gene [5]. Unaffected
individuals have 6–55 CGG repeats and affected individuals
have 55–200 repeats [6]. DM1 is an autosomal dominant
disorder which is characterised by clinical features such as
muscle weakness, myotonia, and heart defects [7]. DM1 is
characterised by expansion of CTG repeats within the 3󸀠-
UTR of the DMPK gene [8]. Unaffected individuals have 5–
37 CTG repeats and affected individuals have 90 to several
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thousand CTG repeats [9]. These are currently the only trin-
ucleotide repeat diseases that have been studied with respect
to their DNA methylation patterns near the trinucleotide
repeats [2]. All the DNA methylation data and details of the
patients and controls used are prepublished in references 38,
39, and 40. All the CpG sites studied are very close to the
repeat and therefore have the potential to be methylated in
patients due to the repeat expansion.However, they are not all
methylated, as shown in Figure 1. The proximity of the CpG
to the repeat does not seem to be the only factor influencing
aberrant methylation in patients as demonstrated by the FXN
gene, where CpGs that are nearer to the repeat do not show
variability in methylation between patients and controls.
A common theme for all of the large noncoding TNR
expansion diseases is DNA hypermethylation of CpG din-
ucleotides near the repeats (3). The mechanism by which
aberrantmethylation occurs is poorly understood, but several
theories have been put forward. Short interfering RNAs
(siRNAs) produced by bidirectional transcription across
TNRs may recruit histone methyltransferases, HP1, and
DNA methyltransferases giving rise to DNA methylation
[10]. siRNAs have been shown to be produced from gene
promoter CpG islands [11] and at several TNR loci [12–16]
thus making this mechanism possible. Further, it is possible
that siRNAs generated from a different locus may induce
DNA methylation at a TNR locus. Loss of a methylation-
sensitive chromatin insulator and subsequent spreading of
DNA methylation might be another mechanism for DNA
methylation at TNR loci. The insulator protein CTCF is one
possible candidate for this mechanism because it has been
identified in the flanking regions of FRAXA CGG repeats
[14], DM1 CTG repeats [17], and also in the upstream regions
of FRDA GAA repeats [15].
DNAmethylation in TNR expansion disorders is thought
to result in the silencing of gene transcription by two general
mechanisms (i) preventing binding of basal transcription
protein or other regulatory DNA binding proteins (e.g.,
CTCF) and (ii) influencing nucleosome positioning or sta-
bility and reinforcing heterochromatin formation through
the actions of methyl CpG binding proteins (MBPs), histone
modifications, and chromatin remodelling [18]. TNR expan-
sion disorders characteristically show trinucleotide instability
which plays a significant role in the progression and aetiology
of the disease. DNA methylation in these diseases appears
to influence the dynamics of that stability [9]. Thus, DNA
methylation is not only a mechanism by which the disease
is caused but a mechanism by which it develops.
Particular motifs have been identified which predict
the methylation status of DNA sequences in normal cells.
Notably methylation is more prevalent in regions of low CpG
density, with regions of intermediate density beingmost vari-
ably methylated [19]. Computational methods have also been
used to show that the frequencies of CpG, TpG, and CpA are
different between unmethylated and methylated CpG islands
[20]. Further, Yamada and Satou [21] used machine learning
by support vector machine and random forest using previ-
ously reported methylation data to analyse DNA sequence
features to predict methylation status. They revealed that fre-
quencies of sequences containing CG, CT, or CA are different
between unmethylated and methylated CpG islands. Ali and
Seker [22] used an adapted K-nearest neighbour classifier to
predict themethylation state on chromosomes 6, 20, and 22 in
various tissues.They identified four feature subsets which had
shown that the methylated CpG islands can be distinguished
from the unmethylated CpG islands. Lastly, Previti et al. [23]
used a mining process in the absence of supervised data to
cluster and then predict methylation status of CpG islands
in different tissues and showed significant differences in the
sequences of CpG islands (CGIs) that predispose them to
such methylation. In their review of computational epigenet-
ics, Bock and Lengauer [20] in their review “Computational
Epigenetics” highlighted the fact that, although it is clear
that much work has been done to document the epigenetic
state of the genome (much of it reported in the ENCODE
project (http://www.nature.com/encode/#/threads)), work in
the area of de novo DNA methylation prediction is to date
limited. Aberrant methylation has been shown to be associ-
ated with mutations. Methylation in the MGMT promoter
has been demonstrated to be closely associated with G : C
to A : T mutations [19]. A few studies have attempted to
search for motifs associated with aberrant methylation most
notably Feltus et al. [24] who used Restriction Landmark
Genome Scanning software to identify methylation resistant
andmethylation pronemotifs based onDNA sequence.Their
results suggest that the sequence surrounding a CpG can be
used to predict aberrant methylation. In another study by
McCabe et al. [25], patterns were identified using machine
learning techniques and used for pattern matching. DNA
signatures and a cooccurrence with polycomb binding were
found to predict aberrant CpG methylation in cancer cells.
Previous studies have examined DNA methylation in
different trinucleotide repeat diseases [26–28]. In this study,
we have used a pattern searching algorithm on the com-
bined data from these studies to identify motifs in the
DNA surrounding aberrantly methylated CpGs found in
the DNA of patients with one of the three TNR expansion
diseases: FRAXA, DM1, or FRDA. We examined sequences
surrounding both the variablymethylated (VM)CpGs, which
are hypermethylated in patients compared with unaffected
controls, and the nonvariablymethylatedCpGswhich remain
either fully methylated (AM) or unmethylated (NM) in both
patients and unaffected controls. We expand on the approach
of Lu et al. [29] using a search window of 5 bp allowing up
to 3 mismatches. Any sequence with 4 mismatches is dis-
counted because they represent only a one bp motif. Patterns
identified therefore include mismatches. For example, if the
sequence contains GATCT, it is counted in GA∗∗T, GA∗CT,
where ∗ represents any bp in the motif.
2. Materials and Methods
2.1. Pattern Generation. The three DNA sequences of FXN
[26], FMR1 [27], and DMPK [28] genes involved in the
3 TNR expansion diseases were examined for methylation
status in patients and controls in previous studies. The
methylation results obtained in these previous studies were
used as the data for our work. CpG sites for which their
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Table 1: Table of discriminatory patterns.
Top 10 patterns that separate AM class from
NM and AM
(less frequent in AM than NM + VM)
Top 10 patterns that separate VM class from
AM and NM
(less frequent in VM than AM + NM)
Top 10 patterns that separate NM class from
AM and VM
(less frequent in NM than AM + VM)
ccgg[agct]{0, 1} [agct]{0,1}tttt ta[agct]{0,2}a
g[agct]{0, 1}gcg t[agct]{0,1}cat [agct]{0,1}gcgg
g[agct]{0, 1}ctc catg[agct]{0, 1} [agct]{0, 1}ccgc
cgg[agct]{0, 1}t ga[agct]{0, 1}at c[agct]{0, 1}ccg
ag[agct]{0, 1}ct at[agct]{0, 1}ca ag[agct]{0, 1}gg
cg[agct]{0, 1}tc taa[agct]{0, 1}t c[agct]{0, 1}gcg
cga[agct]{0, 1}c tct[agct]{0, 1}a ag[agct]{0, 1}ac
t[agct]{0, 1}cga [agct]{0, 1}tgca tt[agct]{0, 1}aa
gt[agct]{0, 1}ac ta[agct]{0, 1}ta ctt[agct]{0, 1}a
tcga[agct]{0, 1} ac[agct]{0, 1}ta ttt[agct]{0, 1}a
methylation statuses were available for both disease and
normal cells were tagged. In order to identify patterns in
the sequences flanking these CpGs, all possible sequences
of a window size of 5 bp were generated in similar way to
those used in the study by Lu et al. [29]. DNA of 5 bp
length has been shown in the literature to have significant
roles in biological functions. For example, some of them
are modifying sites and binding sites of enzymes and some
are binding motifs of some transcription factors. It has also
been shown that 5 bp DNA lengths are important for DNA
methylation where they are probably associated with the
binding of DNA methyltransferase [29]. 5 bp long sequences
are important for the binding of many enzymes including
the methyltransferase; both methylases (LlaDII and Bsp6I
R/M) have two recognition sites (5󸀠-GCGGC-3󸀠 and 5󸀠-
GCCGC-3󸀠) [3-0] and 5󸀠-CCCGC-3󸀠 is the recognition site
of the DNA methyltransferase (methylase) FauIA (of the
restriction-modification system FauI from Flavobacterium
aquatile) [30].
Sequences from FXN, FMR1, and DMPK genes were
divided into three classes of region, always methylated (AM),
variably methylated (VM), and never methylated (NM),
where the regions that are variably methylated are aberrantly
methylated in patients and the always and never methylated
regions are methylated and nonmethylated, respectively, in
both patients and controls. Significantly, there is no overlap
between regions. This is shown in Figure 1. Both positive
and negative strands were analysed. For each of these
regions, the 5 bp window “slides along” from start to end of
sequence and the pattern in that window is noted plus some
additional information, the CpG site that patterns occurred
near, location of pattern (using numbering as shown in
Figure 1) and the exact sequence that occurred in the window
(see Table 1 in Supplementary Material available online on
http://dx.doi.org/10.1155/2013/689798).
The patterns identified were ranked in order of frequency
in a region class and the proportional frequency in each
region as calculated by dividing the frequency in that region
by the length of the region in bp.Theproportional frequencies
of each pattern in each region class were calculated by adding
all the regions in that class together giving the sum of that
proportional frequency in that region class. Thus we are
able to determine which patterns are most prevalent in each
methylation region class. We were able to identify patterns
that are not present in any one class and more prevalent in
the other two classes using the sum of the other two classes’
proportional frequencies (Table 1) and also patterns that are
unique in one class and did not occur in the other two classes
(Table 2). This allowed us to determine which pattern(s) best
discriminated between the region classes (Supplementary
Table 1).
Further, to validate and compare our results, we used
MEME software (http://meme.nbcr.net/meme/) to identify
patterns in these same regions. A 5 bp window size was
used and “any number of repetitions” was selected; all other
settings were default.
The WEKA J48 classification technique was used to find
the patterns that best classify the sequences in the three
classes. The patterns of each region were used as attributes in
the analysis rather than the sums of all the regions in the same
class. The patterns were treated as attributes in WEKA and
sequences as instances. We used the WEKA J48 algorithm
(an implementation of the C4.5 algorithm) to generate a
decision tree. We used Witten et al.’s approach to implement
the decision tree to classify the pattern as follows. “First,
select an attribute to place at the root node, and make one
branch for each possible value. This splits up the example set
into subsets, one for every value of the attribute. Now, the
process can be repeated recursively for each branch, using
only those instances that actually reach the branch. If at any
time all instances at a node have the same classification, stop
developing that part of the tree” [31]. Attributes are selected
based on information gain, so in our tree CCGG∗ has the
highest information gain.
To determine if any of the patterns have an identity
to known DNA motifs for such DNA binding proteins as
transcription factors we analysed the patterns identified by
WEKA as distinguishing each region class using TOMTOM
software (http://meme.nbcr.net/meme/) using the Jasper and
UniPROBE databases for the TOMTOM search.
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Never methylated region (CTG)n
60
120
180
240
294
6
66
126
186
(a)
Promoter
Variably methylated region
69–20 CpG sites
Always methylated region
83–70 CpG sites
FMR1
60
120
180
240
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660
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(CTG)n
(b)
FXN
Always methylated region
CpG sites 7, 8
60
120
180
235
(CTG)n
CpG sites 1, 2 and 3
Variably methylated region 4, 5 and 6 CpG sites
(c)
Figure 1: This figure shows the 3 gene regions under investigation: (a) DMPK 3󸀠 UTR region, (b) FMR1 5󸀠 UTR region, and (c) FXN intron
1 region. A scheme of the DNA sequence, transcriptional start site, and the regions analysed are shown. The grey shading shows the always
methylated (AM) regions, blue shows the never methylated (NM), and the yellow area shows variably methylated (VM) regions. CpG sites
are underlined and bold numbers at start and end of each line show base pair number in the sequence. A triangle shows the location of repeat
expansion and the box above triangle shows the TNR repeats. The green highlighted region in the FMR1 gene indicates the promoter region.
The CTCF binding sites are shown in red.
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Table 2: Table of unique patterns in each region.
(a) Patterns unique to VM
Pattern Sum (VM) Sum (AM) Sum (NM)
ga[agct]{0, 1}tc 0.006803 0 0
g[agct]{0, 1}gac 0.010544 0 0
gt[agct]{0, 1}ac 0.014286 0 0
(b) Top 10 proportionally most frequently occurring patterns unique to AM
Pattern Sum (VM) Sum (AM) Sum (NM)
taa[agct]{0, 1}t 0 0.043757 0
tct[agct]{0, 1}a 0 0.043119 0
ta[agct]{0, 1}ta 0 0.038785 0
ga[agct]{0, 1}aa 0 0.034818 0
ta[agct]{0, 1}at 0 0.030483 0
t[agct]{0, 1}tat 0 0.028634 0
at[agct]{0, 1}ag 0 0.026786 0
[agct]{0, 1}atac 0 0.024938 0
a[agct]{0, 1}tag 0 0.024938 0
tat[agct]{0, 1}a 0 0.024938 0
(c) The 8 proportionallymost frequently occurring patterns which aremore
prevalent in NM than in VM and AM
Pattern Sum (VM) Sum (AM) Sum (NM)
[agct]{0, 1}atct 0 0.001848 0.004348
agat[agct]{0, 1} 0 0.001848 0.004348
a[agct]{0, 1}gat 0 0.003697 0.008696
atc[agct]{0, 1}t 0 0.003697 0.008696
[agct]{0, 1}atcg 0 0.005545 0.008696
cgat[agct]{0, 1} 0 0.005545 0.008696
atcg[agct]{0, 1} 0 0.005545 0.008696
[agct]{0, 1}cgat 0 0.005545 0.008696
3. Results
3.1. Frequency. Of all the possible combinations of 5 bp
patterns where 2 or more of the 5 bps are identical within a
pattern for example, CG∗∗∗ is one pattern where patterns of
CGTTG and CGTTA are the actual sequences found. 1584
different patterns were found in all the regions analysed.Most
were found in all 3 genes in all the regions. 1454 patterns
were found in the VM regions, 1563 in the AM regions
and 1264 in the NM region. Two patterns are unique in the
FMR1 gene in both regions. There are no unique patterns
for FXN. One pattern is unique for the DMPK gene in both
regions. Analysis of the patterns revealed that some patterns
did not occur in some regions allowing the region classes to
be separated; these results are shown in Table 1.
3.2. Proportional Frequency. On calculating the sum of the
proportional frequencies of patterns, we found three patterns
are unique for VM regions and 84 are unique to AM. There
are no unique patterns for the NM region. The patterns
which showed the greatest proportional difference between
AM (6.0)
ccgg[agct]{0, 1}
VM (6.0)
≤0.003697
aatt[agct]{0, 1}
>0.003697
NM (2.0)
>0≤0
Figure 2: Decision tree created by Weka package. AM is always
methylated, NM is never methylated (NM) and (VM) is variably
methylated.
the regions are given below and show that there are patterns
which are unique to VM and AM regions. Results are shown
in Table 2.
The summed proportional frequencies of each pattern
for each region class showed a distinct difference in the fre-
quencies of particular patterns in different class regions. Our
results clearly show that some patterns are more prevalent in
some region classes than others and therefore themethylation
status of the regions around the repeats is influenced by
the underlying DNA sequence as well as the length of the
trinucleotide repeat.
3.3.WEKAAnalysis. Thefinding from the frequencies show-
ing that some patterns could be used to distinguish the 3 class
regions from each other was confirmed by J48 classification
decision tree analysis using WEKA software. The results are
given in Figure 2.TheWEKA programme identified that two
patterns are all that is necessary to classify our 3 regions, as
shown in the decision tree.
Using the proportional frequencies of all regions (not
the summed frequencies), we observed that AATT∗ dis-
tinguished between NM and VM + AM using the J48
algorithm where the proportional frequency of AATT∗ is
more than 0.003697 in NM. This result mirrors the result
of the frequency analysis reported above that there are no
unique patterns for the NM region; hence, the distinction is
based on frequency rather than the presence or absence of a
pattern. AM can be distinguished from VM by the sequence
CCGG∗ which is found in VM and not in AM regions.
3.4. Comparison with MEME Software. In order to compare
our software’s predictions to those generated by MEME,
we compared the 10 best distinguishing motifs identified
by MEME, using the any number of repetitions (ANR)
option and a window size of 5 bp, similar to our algorithm,
with the patterns identified by our software. The results are
given in Table 3. The results are comparable, but notably our
software identified more patterns than the MEME software.
No patterns found using the MEME software were missed by
our software.
3.5. CTCF Binding. Since it has been reported that FRDA
patients have depleted levels of CTCF and there is a sug-
gestion that this protein could act to protect DNA from
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Table 3: Comparison of MEME results with patterns found in this study.
(a) 10 best 5 bp motifs in variably methylated regions
Pattern MEME detail positive or negative strand Our software variably methylated
TGTTT FXN+, FMR1+ FMR1+, FXN+
AAACT FXN++− FXN++−
TATTT FXN++ FXN++
TCCAA FXN+DMPK− FXN+DMPK+
TCGAA DMPK+DMPK− DMPK+DMPK−
CTGAG FMR1 −− DMPK+FMR1+FMR1−−
CTGAA FMR1−DMPK+ DMPK+FMR1−
GAGAG FXN−FMR1+ FMR1++FXN−−
TA[CG]AA DMPK−DMPK+ DMPK−DMPK+FXN−
ACCCA DMPK−− DMPK −−
(b) 10 best 5 bp motifs in always methylated regions
Pattern MEME detail positive or negative strand Our software always methylated
AGGGG FXN AM 1++FMR1+ − − FMR1+ − −FXN AM 1++
CCAGC FXN AM 1−FMR1− FMR1+ − −FXN AM 1−
CTGGC FXN AM 2+FMR1+ FMR1+ + +FXN+
CCACC FXN AM 2−FMR1+ FMR1++FXN AM 2−
CCTCA FMR1−− FMR1+− − −
CCGCC FXN AM 1−FMR1+ FXN AM 1−FMR1+
AGCAC FXN AM 2−FMR1− FXN AM 2−FMR1+++−
AGTTG FMR1++ FMR1+++FMR1−−
TAGCA FMR1−FMR+ FMR1+ + −−
AGAAA FXN AM 2+FMR1+ + − − −− FXN AM 2+FMR1++− − −−
(c) 10 best 5 bp motifs in never methylated region
Pattern MEME detail positive or negative strand Our software never methylated
TTTGC DMPK++− DMPK+ + − − −
TTCTT DMPK++ DMPK+++
AGGCA DMPK−+ DMPK+−
TT[AT]CT DMPK++ DMPK++++
CCATC DMPK+− DMPK+−
CAGGC DMPK++ DMPK+ + −−
CAGAC DMPK−+ DMPK+−
TGACG DMPK++ DMPK++
ACC[AT]A DMPK−+ DMPK+−
CTGGG DMPK++ DMPK++
Key:
+ Positive strand.
− Negative strand.
FXN AM 1 and FXN AM 2 are two separated regions with always methylated CpG sites.
Bold: Motif that MEME does not report all occurrences.
targeted methylation in healthy individuals [15], the regions
were analysed for CTCF binding sites to determine if the
differential methylation could be linked not only to DNA
sequence but also to CTCF binding.The diagrams in Figure 1
show the putative CTCF binding sites in the analysed regions.
Since the bindings sites seem to be equally prevalent in all the
region classes, it would seem that simple depletion of CTCF
levels may not be the explanation for the variability in the
methylation in patients compared to controls unless there
are other factors that influence the binding of CTCF to its
site over and above just the binding site sequence. Proof that
CTCF may not be the complete explanation of differential
methylation in patients requires wet laboratory experiments
that are beyond the scope of this paper.
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3.6. Comparison of Patterns with DNA Binding Protein Sites.
Hogart et al. [32] identified overrepresented transcription
factor consensus binding motifs in methylated sequences.
This would suggest that the methylation-sensitive binding of
DNA binding proteins plays an important part in regulating
genes.Thus, the variation in methylation seen in VM regions
could be an important mechanism in these disease states
due to the DNA binding proteins that bind to these regions.
Further, since the binding of DNA binding proteins such
as transcription factors may influence aberrant methylation
patterns, we wished to compare our patterns with binding
sites in the Jasper and Uniprobe databases. TOMTOM anal-
ysis revealed that the CCGG pattern which is found in VM
regions but not AM regions is part of the consensus binding
site for 35 DNA binding proteins; however, not all are found
in mammals. A human protein ELK4, which is predicted
to bind, may be influenced by the degree of methylation
in the promoter of some genes as demonstrated in the
caldesmon gene (CALD1) by Cooper et al. [33]. Another one,
GABPA, whose binding sites are overrepresented in methy-
lated regions of primary mouse hematopoietic stem cells
[32], shows evidence of GABPA binding being methylation-
sensitive as demonstrated by Lucas et al. [34] who showed
that the regulation of TMS1/ASC gene is controlled in such
a way.
TheAATTpatternwhich is foundmore frequently inNM
matched with 151 DNA binding protein consensus sequences,
although very few are found in mammals. However, there
was a preponderance of homeobox domain proteins in the
matches. One protein predicted to bind, PAX6, is inhibited
from binding by methylation of its binding site [35]. Another
one, PAX7, results in H3K4 trimethylation of surrounding
chromatin stimulating transcriptional activation of target
genes to regulate entry into the myogenic developmental
programme in skeletal muscle [36]. There is therefore a
suggestion that these patterns may bind proteins that could
influence gene expression. Wet laboratory experiments are
however required to prove that this is indeed the case.
4. Discussion
Our results show that there are sequence patterns which can
be used to distinguish between AM, VM, and NM regions of
these TNR genes. A single pattern can be used to distinguish
the NM region from the other two. Furthermore, the fact that
the VM regions show a few striking and unique patterns is
particularly notable when the frequencies are summed and
WEKA analysis of nonsummed frequencies shows that one
pattern can be used to distinguish this region class from
AM.This finding could point towards one mechanism which
contributes to themethylation status of these regions of DNA
in patients compared with controls.
The three genes however show differences based on our
classification of the VM, AM, and NM regions. There could
be several explanations for this: for DMPK, the VM region is
upstream of the TNR and has the only NM region in any of
the genes which is downstream of TNR. In FMR1 and FXN,
both VM and AM regions are upstream of the repeat region.
DMPK and FMR1 are similar in the way that their AM region
is continuous unlike FXN which has two disconnected AM
regions. Further, the nature of the TNRs in each of the genes
is different; FXN has a TNR of GAAn, FMR1 has CGGn,
and DMPK has CTGn. Thus, FXN is unique in having only
purines in one strand of its repeat (and only pyrimidines in
the other strand), while the other two repeats are mixtures of
purines and pyrimidines in each strand.
Comparing our software to identify patterns withMEME,
we have demonstrated that our software identifies more
patterns than MEME in these short DNA sequences. MEME
software has been optimised to find patterns in much longer
sequences thus may not be as good as our software for
detecting patterns in short sequences or using small window
sizes. Further, when the results from MEME alone on our
sequences were analysed using WEKA (see supplementary
data), the software gave a less discriminating tree than the
results from our software, thus showing our software is better
at discriminating patterns than MEME.
There are many possible points of discussion that can be
drawn from our data. The report that FRDA patients have
depleted levels of CTCF suggested the possibility that this
protein could act to protect DNA from targeted methylation
in healthy individuals [15]. However, the distribution of
potential CTCF binding sites in the three genes examined
here would suggest that this is not the sole cause of the
variation in methylation seen in the different regions.
It is notable that the restriction sites of the two classi-
cal enzyme pairs HpaII—MspI (CCGG) and SmaI—XmaI
(CCCGGG) used to analyse DNA sequences for methylation
have CCGG at their core. Although not all CpG methylation
occurs within these sequences, much does.This illustrates the
significance of discovering the CCGG pattern as a mark for
VM regions.
DNAmethyltransferases 3a and 3b (Dnmt3a or Dnmt3b)
are the enzymes responsible for de novo DNA methylation
in humans and the mouse. However, the mechanisms by
which specific DNA sequences are targeted to be methylated
are not known, nor are the signals that trigger this phe-
nomenon. The work of Hervouet et al. [37] has shown that
Dnmt3a and Dnmt3b have consensus sequences to methy-
late DNA (T/A/C)(A/T)(T/G/A)CG(T/G/C)G(G/C/A) and
(A/C)(C/G/A)(A/G)CGT(C/G)(A/G). Thus, the propensity
of a methylase to de novo methylate certain CpG may not
happen due to the binding specificity of the enzyme itself
since these sequences demonstrate the low specificity of
these enzymes. Hervouet et al. go on to suggest that the
mechanism is controlled by the interaction of Dnmt3a or
Dnmt3b with specific transcription factors suggesting that
the specificity comes from the binding or not of these
transcription factors to specific sequences in the promoter
regions of genes. It is also possible that there is an interaction
of antisense RNA with specific DNA sequences or with the
methylases themselves to molecules that may aid in the
directing of de novo methylation. Epi-miRNAs have been
demonstrated to regulate or possibly direct the epigenetic
machinery as reported in a review by Iorio et al. [38]. Either
of these mechanisms could lead to the more directed de novo
methylation seen in vivo and therefore could explain the
8 Journal of Nucleic Acids
differences between the logos characterised for the 3 different
genes investigated in this work.
Such aberrant methylation is well known to cause down-
regulation of genes resulting in disease states by very different
mechanisms. In cancer, the aberrantmethylation is not under
the influence of TNRs present near the genes; thus, the
mechanism giving the observed variation in methylation
in these genes is probably subtly different. Furthermore,
the resulting methylation may result in different effects.
In FMR1, DNA methylation prevents the binding of the
transcription factor 𝛼-Pal/NRF-1, whereas methylation of the
FXN intron 1 region may be involved in the formation of a
transient purine ⋅purine⋅pyrimidine DNA triplex preventing
transcriptional elongation [39]. Recently microRNAs have
been hypothesised to have a role in the downregulation of
genes. It has been shown that microRNA expression can be
modulated by promoter methylation or histone acetylation,
a phenomenon that is found in numerous diseases including
FRDA. Also antisense RNAs may be more highly expressed.
Interestingly, the work by De Biase et al. [15] shows the
presence of increased amounts of a novel transcript FAST-
1 (FXN antisense transcript-1) in FRDA patients which may
prove to be significant.
Thus, we present evidence that the DNA sequence sur-
rounding a CpG can influence its susceptibility to be de novo
methylated in a disease state associated with a trinucleotide
repeat and that our work could form the basis of directed
wet laboratory experiments to prove the phenomenon. This
supports the findings of other investigators who have made
similar findings in cancer cells [25]. Our results represent
those from only three of the numerous trinucleotide repeat
associated diseases since data for the other diseases is unavail-
able at this time. We acknowledge therefore that further
work to elucidate the involvement of DNA methylation and
then the DNA sequence around any methylated CpG islands
in patients is required to build a complete picture of this
phenomenon in this classification of diseases.
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